← All organizations

Instituto de Medicina Molecular

Academic/Hospital

Highest phase reached

Phase 3

First clinical trial

Aug 1, 2014

Last known activity

Mar 1, 2015

Timeline

No events for the selected filters.

Drugs by trial phase (3 distinct, 2 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

Indications

Recent trials (5)

  • NCT02385019Reponsible party - principal investigatorPhase 1/Phase 2Mar 1, 2015
  • NCT02385019Lead sponsorPhase 1/Phase 2Mar 1, 2015
  • NCT02065713Overall official - principal investigatorPhase 3Aug 1, 2014
  • NCT02065713Reponsible party - principal investigatorPhase 3Aug 1, 2014
  • NCT02065713Lead sponsorPhase 3Aug 1, 2014

Details

Last known activity
Mar 1, 2015